Electrophysiological measurement of anterior cingulate cortex (ACC) function in schizophrenic patients treated with Seroquel or Fluanxol.

Trial Profile

Electrophysiological measurement of anterior cingulate cortex (ACC) function in schizophrenic patients treated with Seroquel or Fluanxol.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Quetiapine (Primary) ; Flupentixol
  • Indications Schizophrenia
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 06 Jul 2012 Status changed from recruiting to completed as reported by German Clinical Trials Register.
    • 11 Jun 2012 New source identified and integrated. Added study centres, dose information and AstraZeneca as trial sponsor.
    • 13 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top